IL6 and neoplasm: Combination with IL‐6 blockade is not effective for sensitizing such tumor to ICI (anti‐PD‐1/anti‐CTLA‐4), but neutralization of IL‐6 along with stimulation of CD40 can cause tumor sensitization to ICI.